Selfcare, Inc.'s OTC electrochemical blood glucose monitor to be marketed by LifeScan.
This article was originally published in The Tan Sheet
Executive Summary
SELFCARE'S OTC ELECTROCHEMICAL BLOOD GLUCOSE MONITOR KIT PENDING AT FDA; the company filed a 510k application in late May. The test kit will be marketed by Johnson & Johnson subsidiary LifeScan under a November 1995 worldwide alliance with Waltham, Mass-based Selfcare. LifeScan, the leader in the OTC blood glucose test market, does not currently market an electrochemical test. Plans for the product were disclosed by Selfcare in a preliminary prospectus for an initial public offering.